Verity....Thanks for your valuable insights on the 4th quarter conference call, Your comments regarding the future of the CF pipeline are most exciting and encouraging. 809, 661 and 770 will turn the treatment of CF into a disease that has normal life expectancy, with a more normal quality of life being restored to 70,000 young people. Breakthrough drug status has net yet been defined by the FDA or Vertex in terms of how quickly these drugs will be released, but the CFcommunity needs to keep the FDA true to honoring the committment to facilitate expediting postive clinical trials and translating positive interim results into early provisional approval of these drugs at six months of testing to allow the sickest CF patients a shot at salvaging their pulmonary function and stabliizing their condition. Best wishes to you and your CF child and all the families with CF who share your hope and optimism. Those of us investing in this most worthwhile of projects may succeed finiancially on this breakthrough, but the greatest success will be in hearing that your child and the others like him or her will be reporting their improved health and quality of life in the coming year.
Thanks. Tears in my eyes from your compassionate note. And I can't wait to report back in a few years that ds is no longer doing two hours of treatments and tenish meds each day. And that we no longer own stock in Purell!